Mr Wood pleaded guilty to three charges of making indecent images of children at Portsmouth Magistrate’s Court in December 2017. Following his conviction, Mr Wood was given a community sentence, fined and made subject to a sexual harm prevention order for five years.
Mr Wood’s application for restoration was based on the argument that he was professionally competent to be restored to the Register, that he had strong mitigation for his original conviction (for which he had demonstrated remorse), that he had a low chance of reoffending, had engaged proactively with the Probation Service and rehabilitative courses, and that had completed his community service.
In considering Mr Wood’s application, the Disciplinary Committee took into account a number of factors including Mr Wood’s acceptance of the Committee’s original findings, the seriousness of the original findings, protection of the public, the future welfare of animals in his care should he be restored, the length of time off the Register, his conduct since removal from the Register, efforts by Mr Wood to keep up-to-date with his continuing professional development (CPD), the impact of removal from the Register on Mr Wood and public support for his restoration.
However, on balance, the Committee decided that Mr Wood was not currently fit to be restored to the Register.
Ian Arundale, chairing the Committee and speaking on its behalf, said: "In essence, the Committee decided that the facts of the charge justifying removal from the Register and the underlying criminal behaviour were too serious for Mr Wood to be restored at this time. It concluded that because Mr Wood continued to be subject to a sexual harm prevention order, notification requirements for sexual offenders and because he remained on the Barring List by the Disclosure and Barring service until January 2023, he was not fit to be restored to the Register at this time.
"The Committee accepted that Mr Wood had made significant efforts to rehabilitate himself but it was not persuaded that he was fit to be restored to the Register because ancillary orders relating to the underlying criminal offences remained in force. The Committee noted that at the time those orders were made Mr Wood was described as having an addiction and although the Committee accepted that there was a low risk of future reoffending, it decided that because the orders were still in place for public protection reasons, Mr Wood was not fit to be restored to the Register."
The full report of Mr Wood’s restoration hearing can be found at www.rcvs.org.uk/disciplinary
Kruuse has launched the Buster Premium Dog Collar, described as the greatest innovation in Elizabethan dog collars since the original.
The company says the new collar has been designed with two things in mind. First and foremost, patient comfort. Secondly, ease-of-use. Both should help improve compliance.
The new product uses perforated neoprene to provide a snug fit round the neck with no need to attach a separate collar. It's fastened using Velcro, to give a quick but secure fitting. There's padded banding around the inner edge to provides extra comfort and prevent skin irritation, and additional banding around the outer edge to protect the dog's surroundings.
Andrew Groom, Managing Director at Kruuse said: "Worldwide, the Buster collar is the most trusted device to prevent canine patients from biting or licking their body or scratching their head and neck while wounds or injuries heal. The functionality of an e-collar is outstanding when it comes to postoperative care and prevention of self-inflicted trauma.
"The new Buster Premium Collar has been developed in association with vets, vet nurses and dog owners to provide an exceptional collar that is as stress-free as possible for the patient whilst providing exceptional functionality for the user both at the veterinary hospital and at home."
The Premium Buster Collar is available exclusively via NVS: www.vetwholesaler.co.uk
The programme gives farmers and veterinary surgeons access to new resources, enabling a coordinated and consistent approach to farmer training in the responsible use of antibiotics.
The development of the AMBP Programme has been led by NOAH in partnership with a group of stakeholders from across the industry including farmers, vets, the Responsible Use of Medicines in Agriculture Alliance (RUMA), the Veterinary Medicines Directorate (VMD), the British Retail Consortium (BRC) and leading academics, to create a training programme for all those working in the sheep, dairy, beef and pig sectors.
NOAH says the programme will raise awareness, knowledge and understanding of antimicrobial resistance (AMR) and help drive best practice in a consistent manner across UK farms when it comes to using antibiotics.
Training modules are available for farmers to access via the NOAH website or directly through an online Lantra eLearning platform.
In addition to the direct farmer offering, veterinary surgeons will also be to access resource materials, enabling them to deliver training to their clients. This veterinary resource centre will follow soon.
NOAH Chair, Gaynor Hillier, said: "We know that there is a real demand for this type of accessible training and we’re delighted to be able to lead the way in making it available.
"This new collaborative, cross-sector strategy on training will support both farmers and vets, demonstrating that our farmers have the skills to use antibiotics responsibly, providing reassurance to consumers and policy makers. NOAH is happy to be building on existing antibiotic stewardship achievements within the farming sector as ensuring best practice is vital to safeguard the future efficacy of antibiotics for us all.”
Biosecurity Minister Lord Gardiner said:
"The UK is at the forefront of global efforts to tackle antibiotic resistance. Recent statistics show there has been a 27 per cent drop in use of antibiotics in food-producing animals in the UK since 2014 - meeting a government commitment two years early.
"Our farmers and vets must be commended for driving down antibiotic use in livestock to this all-time low - setting an excellent example for others around the world to follow. But it is vital we continue making progress.
"We welcome this new responsible use of antibiotics farmer training programme, which will support the animal medicines industry to take another positive step towards tackling resistance, safeguarding antibiotics for future generations."
Photo: Lord Trees introduced the launch event and outlined his support for the AMBP programme.
Bordetella bronchiseptica is a clinically significant pathogen for canine infectious respiratory disease (CIRD), otherwise known as kennel cough, with 78.7% of dogs with acute respiratory signs testing positive for the bacteria1.
In the same study, 45.6% of clinically healthy dogs also tested positive for Bordetella bronchiseptica, illustrating that clinically healthy dogs can carry respiratory pathogens and could act as sources of infection for susceptible dogs1.
Administered via subcutaneous injection, Canigen Bb is an inactivated subunit vaccine which offers vets a new option when intra-nasal vaccination with a live aerosolised vaccine is not possible or preferred, for example when the dog is in contact with known immunocompromised individuals.
Licensed for use in dogs from 6 weeks of age, Canigen Bb extends protection against Bordetella bronchiseptica in dogs vaccinated with Canigen KC in the last 12 months for a further year with a single dose.
Canigen Bb is presented as a ready-to-use formula in a 10ml multi-dose bottle and can be stored at room temperature (2°C - 25°C) for up to 4 weeks once broached.
It can be administered concurrently (at the same time but separate injections) with Canigen DHP, Canigen DHPPi, Canigen Pi & Canigen Lepto 4.
Andrew Connolly, Marketing Director at Virbac, said: ‘It is our hope that Canigen Bb will increase the overall uptake of Bordetella bronchiseptica vaccination to provide increased protection against this widely prevalent and clinically significant disease’.
Reference
Bovalto Respi vaccines contain a newly developed combination of viral and bacterial antigens. Merial says the recent vaccine isolates effectively target current European-circulating Bovine Respiratory Disease (BRD) strains. Bovalto antigens are also proven by challenge, including at six months post-vaccination to confirm long-lasting protection.
Henry Berger, Global Head of the Ruminant and Equine Business Unit at Merial, said: "Merial is committed to understanding the needs of cattle producers and delivering unique, targeted solutions. Merial is dedicated to expanding its portfolio of parasiticides, vaccines and other disease prevention solutions, with high-value products like Bovalto Respi, to improve productivity, and keep herds healthy."
Merial highlights that BRD is complex to manage and each year affects an estimated 1.9 million animals1, costing the UK cattle industry around £60 million2. In Ireland BRD is responsible for 30% of deaths in stock under one-year old3.
At a Merial symposium at WBC 2016, Prof. Sandro Cavirani, Director of the Department of Animal Health at the University of Parma, Italy highlighted the importance of successful BRD control programmes in calves to optimise herd immunity and productivity, including early, repeated and targeted BRD vaccination.
Bovalto Respi 3 contains strains of Parainfluenza Virus 3, Bovine Respiratory Syncytial Virus, and Mannheimia haemolytica serotype A1. The combination in Bovalto Respi 4 combines the three pathogens in Bovalto Respi 3, with the added strain of Bovine Viral Diarrhoea Virus (BVDV).
References
Finn, a seven-year-old German Shepherd dog, sustained stab wounds to the head and chest as he and his handler, PC David Wardell, pursued a suspect in Stevenage. PC Wardell sustained stab wounds to his hand.
Finn was rushed to Roebuck vets in Stevenage where his wounds were dressed and he was stabilised before being transferred to Davies Veterinary Specialists near Hitchin for emergency surgery.
DVS soft tissue surgeon Rob Adams (pictured above) operated on Finn. He said: "For legal reasons we cannot disclose the full extent of Finn’s injuries. We are however able to confirm multiple knife injuries were sustained to his head and chest involving several of his vital organs. Major surgical intervention was required including open chest surgery to save Finn’s life. Several drains were placed after surgery to manage the degree of trauma and contamination risk from the knife. The surgery went very well and Finn was transferred to intensive care for recovery.
"It is a testament to Finn’s incredible bravery, tenacity and loyalty to his handler, to know he continued to stand firm in the line of duty with no regard to the extent and severity of the injuries he suffered."
DVS says that Finn has exceeded all expectations and recovered very quickly. He has been discharged back into PC Wardell’s care and will hopefully be back up and running again just before Christmas.
PC Wardell said: "I’ve had Finn since he was about nine months old and we’ve been out on the street for just over six years together. It’s just great to have him home. I knew he was in safe hands with Rob Adams but because of the extent of his injuries I was so worried I was going to lose him. Finn’s not only my loyal partner at work but he’s also a part of our family. He has a home for life with me - I can’t imagine life without him."
Meanwhile, a campaign is underway to give police dogs and horses the same status as officers if they are injured in the line of work, so that people who attack police animals face charges similar to those for attacking a person.
You can sign the 'Finn's Law Petition' here: https://petition.parliament.uk/petitions/168678
The campaign also has a twitter feed here: https://twitter.com/FinnsLaw
Virbac says Michelle is widely recognised as one of the world’s leading experts in companion animal reproductive biology.
She graduated from Washington State University College of Veterinary Medicine, before completing a residency at Cornell University and becoming board-certified in Theriogenology.
She earned a PhD in physiology at Cornell University and is currently a Full Professor at Oregon State University.
Michelle is also a member of the WSAVA Reproduction Control Committee which recently previewed its new Global Guidelines for Reproduction Control during WSAVA Congress in September.
Dr Neil Mottram MRCVS, Technical Manager at Virbac said: "The UK has the highest rate of surgical castration in Europe, but with new WSAVA global reproduction control guidelines expected to be published imminently, increasing evidence on the effect of surgical castration on long-term health and even the UK’s leading animal welfare charities updating their guidance on neutering dogs, there’s no better time to review practice neutering policies.
"In line with an evidence-based approach, we want to pose the question: is surgical castration right for every dog?"
www.bit.ly/caninecastration
In a European first, Pfizer Animal Health is conducting a major study in over 2000 dogs with Trocoxil, its new NSAID which delivers continuous analgesia for a month.
According to the company, Trocoxil has already been granted a licence by the EMEA and pre-authorization studies have already shown once-monthly Trocoxil to be at least as safe and effective as daily carprofen. However, the monthly dosing regimen represents such a big step from the currently used approach of daily NSAID dosing, that Pfizer has decided to initiate the study before launching the product in order to closely monitor and manage the introduction of Trocoxil to the veterinary market.
Jolian Howell, Associate Director Companion Animal Marketing for Pfizer said: "A drug with such a unique dosing regimen should be introduced in a controlled and managed way, and this study is part of that commitment by Pfizer Animal Health."
This large post-approval study, conducted under veterinary control as a User Experience Study, will enable a similar comparison with carprofen to be made in a much larger patient population. In fact it will be sufficiently large to provide product-specific safety information, such as any differences in the incidence of side-effects.
The randomised, parallel group study is being conducted in more than 100 veterinary clinics throughout France, Germany and the UK. Each dog will receive up to 6 months of treatment during which time it will be assessed every month by the veterinary surgeon.
Trocoxil, a preferential COX-2 inhibitor, has a unique pharmacological profile which means that a single oral dose provides continuous pain relief for a whole month.
Jolian added: "This study will provide veterinary surgeons with an opportunity to experience the benefits of using Trocoxil to treat OA continuously over a period of months. It will also give them the opportunity to assess the benefits this offers the owner."
Dechra says phenobarbital is effective as a monotherapy in 60 to 80 per cent of dogs with idiopathic epilepsy, but that in 40% of dogs, seizures cannot be controlled with phenobarbital alone. In these cases the company's potassium bromide treatment Libromide, is licensed to be used alongside Soliphen as a concurrent therapy.
According to the company, the combination of phenobarbital and potassium bromide has been shown to reduce seizure number and severity in dogs with refractory idiopathic epilepsy; in tests, the combination treatment reduced the mean seizure rate from 27.4 seizures per month to 2.2 seizures.
Dechra Veterinary Products Brand Manager Craig Sankey said: "Epilepsy is the most common chronic canine neurological disorder, affecting around 0.62 per cent of dogs.
"It can be a distressing condition for both the animal and its owner so we are launching a therapy that can reduce the number of seizures in even the most challenging cases.
"We have also produced new guidelines for prescribing vets, detailing step by step how the treatments can act alone or concurrently. We believe using Soliphen as a sole therapy or in conjunction with Libromide will make a positive contribution to veterinary professionals in their ongoing treatment and management of dogs with epilepsy."
For more information, visit www.dechra.co.uk
So, it suggested, "Kill two birds with one stone" should become "Feed two birds with one scone", "Taking the bull by the horns" should become "Take the flower by the thorns", and "Bring home the bacon", "Bring home the bagels."
Oh honestly. This really gets my goat.
The elephant in the room, of course, is that there's always more than one way of skinning a cat.
Still, PETA went to the dogs years ago.
The Prince's Trust 'creates life-changing opportunities' for those aged 11-30 and Nick has long-held a passion for making a difference to young lives. He has set up three charities for young people: with learning disabilities; who want to campaign to change the world; and who want to break down the barriers to enjoying nature and the outdoors.
Nick has led the RCVS since September 2012. During his tenure, developments at the College include a new Royal Charter, major governance reform, improved regulation of veterinary nurses, the instigation of Vet Futures, the introduction of the alternative dispute resolution service, significant evolution within the Practice Standards Scheme, the refocusing of RCVS Trust into RCVS Knowledge, the launch of Mind Matters, and the recognition of the College as a Great Place to Work.
Nick said: "It has been a great privilege to be CEO of the College and to work with such amazing staff, such a progressive Council and such a decent and caring profession. It is no surprise to me that vets and vet nurses are among the most trusted professionals in this country, and in my view this is due to their professionalism and to the excellence of the Royal College in maintaining and advancing standards. I hope I have played my part in helping the College and the profession navigate through a period of great change and preparation for significant change to come.
"At The Prince’s Trust I will be focused on the next generation, helping to give young people the confidence and purpose they need to make a success of their lives and the world around them. I know from my own personal experiences of school, and the various charities with which I have been involved, how many young people are not given the best chance in life. I cannot think of a better mission to take on."
RCVS President Chris Tufnell said: "I feel very fortunate to have worked closely with Nick over his five years with the RCVS; he has made a tremendous contribution to the College and our professions. With his energy and drive, he has infused the College with a culture of openness, engagement and dedication and has inspired the team through some impressive achievements.
"Nick’s leadership will enable vets and veterinary nurses to fulfil their potential and it's fitting that he's moving on to a role which benefits the lives of others. Meanwhile, there's a considerable amount of important work being done by the RCVS and I am confident that we have a strong team at Belgravia House to manage this until the new CEO is in post."
The RCVS says its Operational Board will be reflecting on Nick’s successes and the future needs of the College, before developing a specification for the new CEO and a recruitment process over the coming weeks.
Having had a three-month sabbatical working at Fitzpatrick, Jonathan decided to relocate from New Zealand where most recently he'd been Head of the Companion Animal Group at Massey University.
Jonathan said: "My prime passion is working directly with animals and their families in a supportive and exceptional clinical setting. I enjoy pushing boundaries and not accepting the status quo. I want to identify better ways of improving outcomes for patients, and minimising the impact of the disease (or its treatment) on an animal’s quality of life. My sabbatical at Fitzpatrick Referrals exposed me to their tremendous energy and real passion for patient and client care. From the moment the clients walk in the door, I feel there is an embrace that lets people know we truly care and want to do the best for their animal friend. I am looking forward to discovering what we can achieve together. Cancer management is such an important opportunity, with the power to change both animal and human lives positively. The direction and focus of Fitzpatrick Referrals in this area is already incredibly exciting.”
Clinical Director of Oncology and Soft Tissue, Professor Nick Bacon said: "On Jon’s first day of his sabbatical, he jumped right into the team and made an immediate positive impact. He hasn’t looked back. He carries with him such a good energy, which we all absorb and hopefully reflect back. His knowledge of implant design for dealing with defects in the mandible and elsewhere is exceptional and I am looking forward to watching that develop. I am also very pleased that Jon’s wife Sharyn is able to join the team; she is very experienced in the field of advanced imaging in humans, including Fluoroscopy and PET-CT. This is already benefitting our patients as we improve our diagnostic and treatment abilities, and get ready for the future."
Jonathan has active research interests in several clinical areas including soft tissue sarcoma, injection-site sarcoma, endoprosthetics and haemangiosarcoma. He also supports the concept of One Medicine as his PhD research into soft tissue sarcoma, haemangiosarcoma and endoprosthetics has a potential relevance in improving the understanding of treatment paradigms for humans and animals.
Taking place at Code Node, VSGD Live will bring together 300 veterinary professionals, offering TED-style talks, Q&A sessions, small group workshops, panel discussions, a VSGD art gallery, awards, and time for networking.
On day one, the event will explore the options open to veterinary surgeons, with talks from those who've stayed in practice, left the profession or diversified their career paths.
There to share their experiences will be Julie Ross (From the clinic to consultancy), Niall Connell (Discovering life after ill health retirement), James Greenwood (Presenter, vet, potter), Jade Statt (Starting Streetvet), Greg Dickens & Guen Bradbury (Work to innovate), Chris Tufnell (Advocating for the profession in practice), Rob Petitt (Mind over matter and surgery), Kimberly Wells (Talk is cheap action is priceless lessons from welfare and Cal Major (Paddling against plastic).
On day two, there will be small group workshops and panel discussions to help you build the confidence and knowledge to move into a new career path or gain a new skill. Subjects include:
Working out what you want: Vet Your Life!
Stop selling yourself short: CV clinic
Taking an idea to business
Practice makes perfect: Starting a veterinary business
Becoming a portfolio professional or a part-time pro
Working in science and communications
Careers in education
Carving out a charitable career
Beyond veterinary: working in the civil service
Locumming: be the independent professional
Lunch on both days is included, as well as drinks and nibbles on Saturday night.
All ticket holders will also receive a follow up e-book with top tips, videos and advice from the inaugural VSGD LIVE! event.
Now, when you search Google for something which includes the word 'job' or 'jobs', Google presents an easy-to-filter list of local vacancies. You can also search in other locations.
One of the criteria for a job advert to be listed in Google for Jobs is that it must first have appeared on a webpage written with special code which allows the search engine to read the advert correctly.
VetSurgeon Jobs has been upgraded to include this code, and jobs advertised on VetSurgeon.org are now appearing on Google for Jobs.
VetSurgeon Editor Arlo Guthrie said: "We've known this was coming for some time, so we made sure VetSurgeon Jobs would be ready as soon as Google unveiled the new system.
"It has yet to be seen how widely Google for Jobs will be used by veterinary surgeons looking for a job. Back in the day, you'd have to wait for the latest copy of Vet Times to arrive in the post in order to find a job. Then came the internet, and with it a small handful of job websites worth checking for veterinary vacancies, of which VetSurgeon Jobs is one.
"Now, Google for Jobs provides one-stop search from most of the big players, although not all veterinary job boards are compatible with the new system and notably Indeed is excluded from Google for Jobs search results.
"The question now is whether jobseekers will continue to go directly to their favourite job website, or search Google first. Either way, though, you'll find jobs advertised on VetSurgeon.org!"
What do you think of the new Google for Jobs feature? Comment below.
If you buy 12 bags from the listed Veterinary Care Nutrition and Satiety Range, you'll get three outers of feline wet food free. Order a minimum of 12 bags and you'll also get a free standing display unit, twelve 50th Anniversary tins and a 50th Anniversary promotional pack. If you buy another eight bags from the listed Canine and Feline Veterinary Care Nutrition and Clinical range, you'll get one box of 12 Anniversary Tins free.
The 50th anniversary promotion pack includes bunting, a window cling, bag stickers and posters.
Erin Biss, Marketing Executive at Royal Canin, said: "50 years on, we continue to put science at the heart of everything we do. From our specially developed diets, to investment in education, supporting important research projects and collaborating with the UK’s universities. We hope vet practices around the UK will join us in celebrating this milestone.”
For more information about Royal Canin's 50th anniversary offer, speak to your Veterinary Business Manager.
The article looks at the practice, rationale and motivation for raw feeding before evaluating the existing evidence on both the benefits and risks of such diets.
The recent trend away from heat-treated, manufactured pet food for dogs and cats towards raw diets has been driven by suspicion of the former and perceived health benefits of the latter.
However, feeding raw diets, even commercially-prepared ones, does have risks: a recent paper described 13 cats in the UK that appeared to have been infected by Mycobacterium bovis2 by feeding Natural Instinct Wild Venison, a commercial raw mince for cats.
The leader of the investigation, Professor Danièlle Gunn-Moore from the University of Edinburgh said: "Feeding raw food was the only conceivable route of infection in most cases; this outbreak of tuberculosis has now affected more than 90 individuals in over 30 different locations, with more than 50 of the cats developing clinical disease."
One of the authors of the review, Dr Andrew Wales, said: "Formal evidence does exist for claims by raw‐feeding proponents of an altered intestinal microbiome and (subjectively) improved stool quality. However, there is currently neither robust evidence nor identified plausible mechanisms for many of the wide range of other claimed benefits.
"There are documented risks associated with raw feeding, principally malnutrition (inexpert formulation and testing of diets) and infection affecting pets and/or household members. Salmonella has been consistently found and there is also a risk of introducing antimicrobial-resistant bacteria."
The full review article can be found in the June issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here https://onlinelibrary.wiley.com/doi/10.1111/jsap.13000
505 people took part in the survey in August 2019, of which 85% were receptionists. The remainder were RVNs, VCAs or practice managers with some front desk responsibility.
The survey found that 45% were paid between £8 and £9 per hour, with 9% more falling into this salary bracket than in 2018. 5.32% were paid £8 or less per hour.
The Real Living Wage is a figure calculated from the costs of a basket of household goods and services by the Living Wage Foundation, and voluntarily paid by its 6000-odd member companies in the UK. The Living Wage Foundation argues it is a better measure of what people need to get by on than the Minimum Wage (£7.70 for those aged between 21 and 25) or the National Living Wage (£8.21 for those over 25).
63% of veterinary receptionists said they were unsatisfied with their pay. However, it was not the biggest cause of dissatisfaction uncovered by the survey. 67% were dissatisfied with the recognition of the value of their role, and 69% with the career progression options open to them.
70% of respondents said they would like to do more CPD and that the main benefit would be to clients and patients. However, 43% of receptionists said there is no time allowance set aside for them to complete CPD.
Co-founder of BVRA and Honorary Associate Professor In Veterinary Business, Nottingham University, Brian Faulkner (pictured right) said: "A large part of the client experience is centred around the waiting room and receptionist area and our members work hard to ensure that experience is positive.
"We have an increasing number looking to upskill and the appetite for CPD is clearly there. If we can envisage a scenario where the minimum wage is set at £10.50 an hour, that would mean that around 65% of veterinary receptionists would need a pay increase.
"I don't think any of us believe that veterinary receptionists are currently doing an unskilled job and a key mission of BVRA is to achieve greater recognition of the value they bring to practices, both as colleagues and commercially."
Meanwhile, the BVA has published the results of its latest Voice of the Profession survey which found that 99% of vets have seen pets in the last 12 months which should have been brought to them for treatment earlier, with 91% reporting that financial reasons were the main factor.
52% of vets also said the number of clients reporting difficulty covering the cost of preventative veterinary care for their animal had increased compared to 2021.
This figure rose to 70% when it came to covering the cost of diagnostic care and treatment.
The Dogs Trust survey, which was carried out by YouGov, asked owners how easy or difficult they would find it to pay vet bills of varying amounts.
10% of pet owners said they would find it fairly difficult to pay unexpected vet bill of £100.
5% said they would find it very difficult.
Overall, 13% said they either cannot afford, or are struggling to afford, the costs of owning a dog in the current climate.
Meanwhile, the charity reports it is getting record numbers of owners asking to hand over their dogs: an average 188 handover requests per day in February compared to an average 141 handover requests per day in 2022, which was itself a record-breaking year (ending in over 50,000 rehoming requests).
In response, Dogs Trust has set up dog food banks at some of its rehoming centres across the UK, which are open to anyone struggling to feed their dog.
The charity has also started a petition asking the Chancellor to Paws the VAT on pet food and veterinary services: https://www.dogstrust.org.uk/support-us/campaigns-appeals/cut-vat-petition
When pet owners were asked in the YouGov survey to what extent they would support or oppose the Chancellor removing VAT from vet care and pet food in next Wednesday’s budget, 61% said they would support it, with 36% of those saying they would strongly support it.
Discuss the value, or not of diagnostics here: https://www.vetsurgeon.org/001/nonclinical/f/life-in-practice-discussions/30519/the-value-or-not-of-diagnostics
www.dogstrust.org.uk
For the study1, treatment and outcomes of ureter injuries due to ovariohysterectomy complications in cats and dogs was undertaken at the Royal Veterinary College. A retrospective case series of cats and dogs with ureteric injuries resulting from ovariohysterectomy was obtained from patient records at the Queen Mother Hospital for Animals. Fourteen female cats and five female dogs were included in the analysis. Descriptive statistics were used to report presenting clinical signs, clinical pathology, treatment and outcomes.
Professor Vicky Lipscomb, lead author of the paper, said “Presenting clinical signs of ureter injury following neutering in this study were non-specific, such as anorexia, vomiting and lethargy. Importantly, the clinical signs consistently developed immediately or shortly after surgery in the majority of animals. Therefore, the appearance of one or more clinical signs following neutering should raise suspicion of a neutering complication.
"The overall outcome for the 19 animals was excellent in 13 (68%), good in one (5%), fair in one (5%) and poor in four (22%). Ureteroneocystostomy (ureteral re-implantation) is preferred to ureteronephrectomy (removal of kidney and ureter) to preserve renal function and is usually a requirement for bilateral ureteric injuries but carries a high complication rate resulting in additional surgery, albeit often with an excellent final outcome.”
Nick Jeffery, editor of JSAP said: “Ovariohysterectomy is a common surgical procedure in cats and dogs, but the procedure carries a (low) risk of injury to one or both ureters due to the close proximity of the female reproductive tract and the ureters. This research highlights the need for vigilance regarding clinical signs following neutering but demonstrates that surgical treatment of ureteric injuries can have good patient outcome."
The full article can be found in the March issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13100
Photo: Luisa Dormer BSAVA
Eurovet has launched Relaquine 35 mg/ml Oral Gel for Horses - a licensed acepromazine (ACP) in a gel format.
The company says Relaquine can be used to sedate horses for examination and in stressful situations that some horses find hard to deal with such as farriery, box rest, dentistry and clipping where highly-strung horses can cause problems. Relaquine is administered orally or mixed with food and is available as an adjustable syringe format containing 10 ml of gel.
Relaquine is the fourth product launch this year by Eurovet and the company says there is more in the pipeline for 2011.
Relaquine Oral Gel is expected to be available to order from veterinary wholesalers from Monday 16th May. Eurovet is also offering an introductory promotion: for further details contact Eurovet on 01223 257933.
The platform, which is available to Premier Pet Care Plan and Animal Healthcare clinics, is designed to help practices increase the number of sign-ups to health care plans.
Romain Regnier (pictured right), PVA’s Business Analyst Manager said: "The current situation has accelerated the need for a digital transformation.
"To help vet practices reach this goal, we have created a highly customisable digital sign-up solution, which mirrors the practice’s branding and can be used in communications to the customer, giving you more possibilities to promote your plans."
With a digital platform, practices can now encourage owners to sign up whilst waiting - socially distanced - outside, or from home.
Debbie Saunders, PVA’s Customer Experience Manager said: "It’s a two-pronged solution; reducing the impact that limited interactions with clients is having on health care plan signs ups and allowing practices to advertise their plans more efficiently.
We are encouraging practices to post about their new digital sign-up links on social media, so pet owners complete their forms anywhere. It will make a big difference to veterinary staff, reducing the amount of administrative pressure from plans but also allowing a direct call to action from advertising."
Each practice will be given unique urls, tiny urls and QR codes which link to the platform, alongside additional marketing materials. The marketing packs contain some customisable content, including social media assets, website banners and printable posters, all free to use to promote the new sign-up platform.
The digital sign-up platforms come with personalisation options, allowing practices to customise their webpage with their own logos, text, and branding, with the help of their PVA trainer.
If you are a Premier Pet Care Plan or Animal Healthcare clinic and are interested in integrating a digital sign-up form into your practice, contact your PVA trainer or call 0117 370 0300 .
Virbac Animal Health has launched Microbex, a POM-V shampoo for the control of Malassezia proliferation and associated clinical signs.
The arrival of Microbex extends the Virbac shampoo range to eight, providing vets with the most comprehensive specialist options in the management of skin conditions, says the company.
Microbex (POM-V) contains 3% chlorhexidine. Product manager Chris Geddes MRCVS said: "Chlorhexidine at this level provides a complete treatment for Malassezia.
"The shampoo also has a flexible application schedule and simple dosing cap, both of which are designed to help improve client compliance and treatment success rate.
Chris added: "Microbex is available in 200ml bottles making it an attractive purchase option for clients."
Further details can be found in the NOAH compendium http://www.noahcompendium.co.uk/. For details on launch promotion contact your local Virbac territory manager or call Virbac on 01359 243243.
On Tuesday 8th September Dr Owen Davies, an RCVS and American Specialist in Veterinary Oncology, will present ‘Mast Cell Tumours: An Update’, in which he will review mast cell tumours and diagnostic approaches before appraising the current treatment options.
On Wednesday 9th September Dr Pam Jones, a double board certified Specialist in Veterinary Medical Oncology and Radiation Oncology from the US, will present ‘Stelfonta: Seeing is Believing’.
Dr Jones will introduce delegates to the unique mode of action of tigilanol tiglate, review the efficacy data behind the new product and demonstrate how this treatment can be used to provide a high tumour elimination rate, wound healing and a speedy return to a good quality of life for the pet.
Dr Neil Mottram, Technical Product Manager at Virbac said: “The effects of Stelfonta really do need to be seen to be believed, so we’re excited to offer vets the opportunity to learn more about this ground-breaking advancement in veterinary oncology. We are lucky to have secured some fantastic speakers for the webinars so delegates can be assured of some top quality CPD.”
Both events will be hosted by The Webinar Vet and begin at 7:30pm. Registration for the event is now open and can be found at www.thewebinarvet.com/stelfonta
For more information, speak to your Virbac Territory Manager or visit vet-uk.virbac.com/stelfonta
According to the company, a similar percentage of respondents believe that senior cats would benefit clinically if they monitored blood pressure routinely in their senior years, and nearly 85% said that anti-hypertensive medication would increase the quality of life for their patients.
Time constraints were cited as the main barrier to routinely measuring blood pressure, but all of those questioned would be happy for a trained RVN to measure blood pressure in cats.
Ceva highlights studies which show show that hypertension affects one in eight cats over nine years old3, with the risk increasing as cats age or if they have other conditions such as chronic kidney disease (where one in three cats suffer with hypertension) or overactive thyroid disease (where an estimated one in four cats suffer with hypertension)4, 5, 6.
Rosanne Jepson, specialist in small animal internal medicine at the Royal Veterinary College said: "High blood pressure can cause severe damage to key body organs including the eyes, kidneys, heart and brain. Unfortunately, it is a condition that develops insidiously without early warning signs for the cat owner; a cat may seem perfectly fine until either the blood pressure is checked, or serious consequences of hypertension suddenly occur."
With this in mind, Ceva says it will host the first Feline Hypertension Month this May, to raise awareness of hypertension and improve the detection and management of high blood pressure in cats.
The company is also encouraging practices to take part in the 'Mercury Challenge', a study it is launching in the summer which will, it says, be the largest-ever European study into feline hypertension.
For information on feline hypertension, Feline Hypertension Month or the Mercury Challenge, contact your local Ceva Animal Health account manager.
Equibactin vet contains sulfadiazine and trimethoprim, and is indicated for use in the treatment of infections, particularly respiratory tract infections associated with Streptococcus spp. and Staphylococcus aureus; gastrointestinal infections associated with E. coli; urogenital infections associated with beta-hemolytic streptococci; and wound infections and open or drained abscesses associated with Streptococcus spp. and Staphylococcus aureus.
The new product has been designed to provide accurate administration to all sizes of horses or ponies. One syringe provides a complete dose for 600kg bodyweight and is subdivided into 12 markings, to help keep track of dosages.
Dechra Brand Manager Emma Jennings said: "Equibactin vet has a proven antibiotic combination with a synergistic effect2 making it an excellent first line broad spectrum antimicrobial treatment for most Gram positive and negative aerobes.
It can be administered without food which improves the oral bioavailability, offering equine veterinary surgeons a quick and efficient treatment when it comes to targeting these infections that are often experienced in day-to-day practice.
"With its ease of use and three-year shelf life, we anticipate that Equibactin vet will quickly become a popular product when it comes to maintaining equine health."
For more information, visit www.dechra.co.uk/products/equine.